Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06721975 · ClinicalTrials.gov registry record · NA
Thulium Fiber Laser (TFL) vs Thulio Pulsed Thulium:YAG (p-Tm:YAG)
A NA study of Nephrolithiasis and Kidney Stones, sponsored by University of California, San Diego.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT06721975: Recruiting NA study of Nephrolithiasis and Kidney Stones, sponsored by University of California, San Diego.
NCT06721975 is a NA study of Nephrolithiasis and Kidney Stones that is actively recruiting participants, run by University of California, San Diego. The registered enrollment target is 50 participants, below the 121-participant average among 16 other Nephrolithiasis trials with a reported enrollment target (59% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06721975, a NA study of Nephrolithiasis and Kidney Stones, is actively recruiting participants, sponsored by University of California, San Diego.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
This research study is being conducted to assess the ability and efficiency of two laser systems to break up kidney stones during ureteroscopy with laser lithotripsy for kidney stone treatment.
Primary Outcome
The primary object is to assess the stone dusting ablation efficiency - efficiency will be defined by amount of laser energy used per stone volume (Joules/mm3)
Conditions Studied
Interventions
- DEVICE Thulio pulsed Thulium:YAG (p-Tm:YAG)
- DEVICE Thulium Laser Fiber (TFL)
Study Locations (1)
California
- University of California, San Diego - San Diego
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2024-08-01 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
What NCT06721975 shows while recruiting
NCT06721975 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 121-participant average among 16 other Nephrolithiasis trials with a reported enrollment target (59% lower).
The record links to 2 conditions, with Nephrolithiasis appearing as the primary indexed condition, and to 2 interventions - of which Thulio pulsed Thulium:YAG (p-Tm:YAG) is the first listed.
NCT06721975 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06721975 about?
NCT06721975 is a clinical study titled "Thulium Fiber Laser (TFL) vs Thulio Pulsed Thulium:YAG (p-Tm:YAG)". This research study is being conducted to assess the ability and efficiency of two laser systems to break up kidney stones during ureteroscopy with laser lithotripsy for kidney stone treatment.
What is the current status of trial NCT06721975?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2024-08-01. Estimated completion is 2026-12-31.
What conditions does trial NCT06721975 study?
This clinical trial studies the following conditions: Nephrolithiasis, Kidney Stones.
What interventions are being tested in trial NCT06721975?
The interventions under investigation include: Thulio pulsed Thulium:YAG (p-Tm:YAG) (DEVICE), Thulium Laser Fiber (TFL) (DEVICE).
Who is sponsoring clinical trial NCT06721975?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06721975 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Nephrolithiasis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06721975's enrollment target sits among peer trials
50 13th of 16 higher than 4 of 16 other Nephrolithiasis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Nephrolithiasis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Endogenous Oxalate Synthesis in Idiopathic Calcium Oxalate Kidney Stone Disease
RECRUITING · NA
-
Methocarbamol vs Oxybutynin for Management of Pain and Discomfort S/P Ureteroscopy Procedure
RECRUITING · NA
-
Gut Oxalate Absorption in Calcium Oxalate Stone Disease
RECRUITING · NA
-
Evaluation of Genetic Abnormalities Amongst Calcium Phosphate Stone Formers
RECRUITING · NA
-
Evaluation of the LithoVue Elite Ureteroscope With Intra-Renal Pressure Monitoring Technology: Examination of Surgeon Behavior and Post-operative Outcomes
RECRUITING · NA
-
O. Formigenes Colonization in Calcium Oxalate Kidney Stone Disease
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI